Crystallization equipment for pharmaceutical APIs
The stirred, draft-tube-baffled, melt and continuous crystallizers — plus the inline FBRM/PVM probes that close the loop on them — that turn a purified API molecule into a defined polymorph with a target particle-size distribution, the unit operation on which bioavailability, purity and downstream filterability all depend.
1 · What it gives
Crystallization equipment for pharmaceutical APIs is the set of vessels, coolers and continuous contactors that drive a purified active pharmaceutical ingredient out of solution into a solid crystal of defined polymorph, particle-size distribution and purity. It is the unit operation on which bioavailability, filterability and downstream drying all depend, and it is where the molecule becomes a processable solid. Three geometries dominate the field: batch draft-tube-baffled (DTB) and Oslo crystallizers for mid-volume APIs, plug-flow and MSMPR continuous crystallizers for high-volume steady-state production, and fractional-melt crystallizers for ultra-high-purity (electronic- or pharma-grade) isolation without solvent handling. The platform is mid-transformation along four axes: inline FBRM and PVM probes that close the loop on chord-length and crystal-shape in real time under ICH Q8 Quality-by-Design; the shift from batch to ICH Q13 continuous crystallization for high-volume APIs; automated parallel screening (Crystal16, Crystalline) that maps polymorph/solvent space in a single overnight run; and fractional-melt crystallization as a green, low-solvent purification route for high-value intermediates.
The key directions of pharmaceutical crystallization equipment are:
- Automated parallel crystallization screening (Crystal16, Crystalline): Technobis platforms that run 16 or 96 parallel small-volume crystallizations under software control, sweeping solvent, cooling rate and anti-solvent composition to map the polymorph/solvent landscape before scale-up.
- Industrial forced-circulation and draft-tube-baffled crystallizers (GEA Messo): the mid-volume workhorse geometry — forced-circulation (FC), draft-tube-baffled (DTB) and Oslo growth-type crystallizers for steroid, vitamin and antibiotic APIs.
- Continuous and melt crystallization (Sulzer Chemtech): plug-flow and MSMPR continuous crystallizers for steady-state ICH Q13 production, and fractional-melt crystallizers that exploit small impurity partition coefficients for electronic- and pharma-grade purity without solvent handling.
- Inline PAT and closed-loop control (Mettler-Toledo FBRM/PVM, ReactIR): inline laser and video probes that track crystal chord-length, shape and supersaturation in real time, enabling Quality-by-Design closed-loop cooling under ICH Q8/Q9/Q10.
Sectoral value chain#
[API solution preparation] ──> [crystallizer (DTB / continuous / melt)] ──> [crystal suspension]
│
(inline FBRM/PVM + supersaturation control)
│
▼
[dried API] <─── [drying] <─── [solid-liquid separation] <─────┘
Value chain levels#
| Level | Description | Key inputs/outputs |
|---|---|---|
| API solution preparation | dissolving the purified API in solvent or anti-solvent at set concentration and temperature | In: purified API, solvent. Out: clear API solution. |
| Crystallization | cooling, anti-solvent, evaporative or melt-driven supersaturation in the crystallizer | In: API solution. Out: crystal suspension. |
| PAT & closed-loop control | inline FBRM/PVM/ReactIR tracking chord-length and supersaturation for feedback cooling | In: crystal suspension. Out: controlled-size crystals. |
| Solid-liquid separation | filtration or decanting of the crystal slurry from mother liquor | In: controlled suspension. Out: wet crystal cake. |
| Drying | vacuum or conical drying of the wet cake to target residual solvent | In: wet cake. Out: dry API solid. |
| Polymorph & release QC | XRPD, DSC and particle-size confirmation against the regulatory polymorph specification | In: dry API solid. Out: released API batch. |
Cross-cutting technologies of the sector:
- Inline FBRM/PVM PAT (FBRM/PVM PAT): focused-beam reflectance and particle-video microscopy probes for real-time chord-length and crystal-shape tracking.
- Continuous crystallization (Continuous Crystallization): plug-flow and MSMPR geometries running at steady state under ICH Q13.
- Melt crystallization (Melt Crystallization): fractional freezing for ultra-high-purity isolation without solvent handling.
2 · What it replaces 3 · matched by industry
3 · How to implement 6 steps
- 1API solution preparationFormulation & blendingThe purified API is dissolved in solvent or anti-solvent at a set concentration and temperature to give a clear, undersaturated starting solution.Who can do this step matched automatically✓ ISO 9001 500 m3“This is a satellite blending, mixing and formulation facility, located at Vashind near Shahapur and dedicated to the company’s Animal Nutrition business.”SyAqua Group Thailand“vannamei genetics (broodstock, nauplii, and post-larvae) built on genomic selection/marker-assisted selection plus quantitative genetics (BLUP), with disease resistance screening …”
- 2CrystallizationPurification & downstreamSupersaturation is generated — by cooling, anti-solvent addition, evaporation or melt — in the crystallizer (DTB, Oslo, FC, plug-flow or melt), nucleating and growing crystals to a target polymorph and size.Who can do this step matched automaticallyTsukishima Kikai Japan✓ ISO 9001“Crystallization and refining: In-house developed DP Crystallizer and Oslo Crystallizer for tailored crystallization and refining processes; integrated purification units combining …”✓ ISO 9001 500 m3“Development of robust, scalable fermentation and downstream processing (production and recovery/yield optimization).”ScaleUp Bio Singapore10,000 L pilot scale“Core capabilities span pilot-industrial fermentation and downstream unit operations (centrifugation, TFF, chromatography, solvent extraction, spray/freeze drying) with cGMP …”HLB Genex (ex-GenoFocus) South Koreaindustrial scale“With fungal and bacterial secretion systems, we custom produce the evolved enzyme products in large-scale fermentation and downstream processes.”
- 3PAT closed-loop controlInline FBRM tracks crystal chord-length, PVM images crystal habit and ReactIR tracks supersaturation, feeding a Quality-by-Design cooling profile under ICH Q8 that holds the process inside the design space.
- 4Solid-liquid separationPurification & downstreamThe crystal slurry is filtered or decanted from the mother liquor on a filter dryer or pusher centrifuge, yielding a wet crystal cake.Who can do this step matched automaticallyTsukishima Kikai Japan✓ ISO 9001“Crystallization and refining: In-house developed DP Crystallizer and Oslo Crystallizer for tailored crystallization and refining processes; integrated purification units combining …”✓ ISO 9001 500 m3“Development of robust, scalable fermentation and downstream processing (production and recovery/yield optimization).”ScaleUp Bio Singapore10,000 L pilot scale“Core capabilities span pilot-industrial fermentation and downstream unit operations (centrifugation, TFF, chromatography, solvent extraction, spray/freeze drying) with cGMP …”HLB Genex (ex-GenoFocus) South Koreaindustrial scale“With fungal and bacterial secretion systems, we custom produce the evolved enzyme products in large-scale fermentation and downstream processes.”
- 5DryingPurification & downstreamThe wet cake is dried under vacuum or in a conical dryer to the target residual-solvent specification set by ICH Q3D.Who can do this step matched automaticallyTsukishima Kikai Japan✓ ISO 9001“Crystallization and refining: In-house developed DP Crystallizer and Oslo Crystallizer for tailored crystallization and refining processes; integrated purification units combining …”✓ ISO 9001 500 m3“Development of robust, scalable fermentation and downstream processing (production and recovery/yield optimization).”ScaleUp Bio Singapore10,000 L pilot scale“Core capabilities span pilot-industrial fermentation and downstream unit operations (centrifugation, TFF, chromatography, solvent extraction, spray/freeze drying) with cGMP …”HLB Genex (ex-GenoFocus) South Koreaindustrial scale“With fungal and bacterial secretion systems, we custom produce the evolved enzyme products in large-scale fermentation and downstream processes.”
- 6Polymorph and release QCTesting & analyticsX-ray powder diffraction (XRPD), differential scanning calorimetry (DSC) and laser particle-size analysis confirm the polymorph, habit and size distribution before batch release against the regulatory specification.Who can do this step matched automaticallyEsco Aster Singapore✓ ISO 9001 5,000 L industrial scale“Esco Aster (Singapore) is a cGMP contract research, development and manufacturing organization (CRDMO/CDMO) and bioinnovation venture accelerator that helps clients and …”Turion Labs Singapore“Turion Labs is a Singapore-headquartered biotech innovation platform that provides shared laboratory infrastructure, contract research organization (CRO) services, and regulatory …”
4 · Who delivers
Matched suppliers (matched automatically)
| Alfa Laval | Sweden | Producer | active |
| KLK OLEO | Malaysia | Research / RTO | active |
| GEA Group | Germany | Distributor | active |
| SyncoZymes (Shanghai) | China | Producer | active |
| Fufeng Group 阜丰集团 (HKEX 546) | China | Producer | active |
| Bühler | Switzerland | Producer | active |
| Sumitomo Chemical | Japan | Producer | active |
In the services and supply catalogue 2 · paid service
Chromatography resins · Downstream — separation & purification
Leading companies and institutes (from the brief)
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| Technobis | 🇳🇱 Netherlands | Crystal16, Crystalline MS, PolyBlock | Automated parallel crystallization screening (16–96 vessels) for polymorph/solvent mapping | Commercial |
| Sulzer | 🇨🇭 Switzerland | SuPro continuous, melt crystallizers | Plug-flow continuous and fractional-melt crystallization for pharma/electronic-grade purity | Commercial |
| GEA Group | 🇩🇪 Germany | GEA Messo DTB, Oslo, FC crystallizers | Industrial forced-circulation, draft-tube-baffled and Oslo growth-type crystallizers | Commercial |
| Syrris | 🇬🇧 United Kingdom | Asia flow chemistry, batch crystallization | Continuous-flow and batch-crystallization platforms (Agilent company) | Commercial |
| Alfa Laval | 🇸🇪 Sweden | Crystallizer heat transfer & MAB | Plate-and-shell heat exchangers and separation for crystallizer duty | Commercial |
| Mettler-Toledo | 🇨🇭 Switzerland | FBRM, PVM, ReactIR | Inline PAT suite (focused-beam reflectance, particle video, mid-IR) for closed-loop control | Commercial |
5 · Rules & route to market
declaration registered within 3 working days (testing extra); certification longer
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States
The United States is the largest demand market for pharmaceutical crystallization equipment — most of the world’s top-20 API manufacturers run US-based process-development and validation groups — and FDA’s ICH Q8 Quality-by-Design and ICH Q13 continuous-manufacturing guidances are the regulatory drivers behind real-time FBRM/PVM closed-loop cooling and the batch-to-continuous transition. The crystallizer OEM base is European, so the US regional block describes the demand-and-adoption side rather than an indigenous OEM.
ICH Q8 QbD adoption, continuous-manufacturing validation, process-development demand#
- FDA ICH Q8/Q9/Q10 Quality-by-Design: the framework that requires a defined polymorph control strategy and real-time release, pulling FBRM/PVM PAT into every new API filing.
- ICH Q13 continuous-manufacturing adoption: US filers lead on continuous crystallization submissions for high-volume APIs, validating plug-flow and MSMPR geometries.
- US process-development demand: the top-20 API manufacturers’ US process-development groups are the primary buyers of Technobis parallel-screening and Mettler-Toledo automated-lab-reactor platforms.
European Union
Europe is the centre of pharmaceutical crystallization equipment manufacturing — all four crystallizer OEM classes and the dominant PAT platform are European. Technobis (Alkmaar, NL) builds the automated parallel-screening platforms; Sulzer Chemtech (Winterthur, CH) builds continuous and fractional-melt crystallizers; GEA Messo builds the industrial DTB, Oslo and forced-circulation workhorses; Syrris (Royston, UK, an Agilent company) supplies flow-chemistry and continuous-crystallization platforms; and Mettler-Toledo supplies the FBRM/PVM/ReactIR PAT suite. EMA’s ICH Q8/Q13 implementation completes the framework.
crystallizer OEMs, PAT platforms, EMA ICH Q8/Q13#
- Technobis — Crystal16 & Crystalline: automated parallel crystallization screening platforms mapping polymorph and solvent space across 16–96 small-volume vessels.
- Sulzer Chemtech — SuPro & melt crystallizers: plug-flow continuous crystallizers and fractional-melt units for electronic- and pharma-grade purification.
- GEA Messo — DTB, Oslo, FC crystallizers: the industrial forced-circulation, draft-tube-baffled and Oslo growth-type workhorses for steroid, vitamin and antibiotic APIs.
- Syrris — Asia flow-chemistry/crystallization (Agilent): continuous-flow and batch-crystallization platforms for hazardous-reaction scale-up.
- Mettler-Toledo — FBRM, PVM, ReactIR: the inline PAT suite (focused-beam reflectance, particle video microscopy, mid-IR) that closes the crystallization control loop under ICH Q8.
China
China is the fastest-growing production geography for pharmaceutical crystallization equipment: domestic API manufacturers supplying steroids, vitamins (ascorbic acid, B-group, D3) and antibiotics are scaling mid-volume DTB and Oslo crystallizer capacity, and NMPA’s adoption of ICH Q8/Q9/Q10/Q13 harmonises the Quality-by-Design and continuous- manufacturing framework with FDA and EMA. The crystallizer OEM base remains predominantly imported (European), so the CN regional block is held qualitative.
API scale-out, NMPA ICH Q8/Q13 alignment, imported OEM base#
- Domestic API production scale-out: steroid, vitamin and antibiotic manufacturers run mid-volume DTB and Oslo crystallizer trains built around European (GEA, Sulzer) and PAT (Mettler-Toledo) hardware.
- NMPA ICH Q8/Q9/Q10/Q13 alignment: harmonised Quality-by-Design and continuous-manufacturing guidance, framing the regulatory route for FBRM/PVM closed-loop and continuous crystallization.
- Imported OEM base: the crystallizer and PAT OEM layer is predominantly European; domestic firms localise media, solvent recovery and downstream drying rather than the crystallizer itself.
6 · Money: tenders & grants
No open tender or grant matched right now.
7 · Tech stack & innovations
The stack combines the crystallizer vessel, the inline PAT probes and the Quality-by-Design control strategy into one closed, validated process.
- Crystallizer geometries (Crystallizer Geometries):
- batch draft-tube-baffled (DTB) and Oslo growth-type crystallizers (GEA Messo) for mid-volume APIs;
- plug-flow and MSMPR continuous crystallizers (Sulzer SuPro) for steady-state ICH Q13 production;
- fractional-melt crystallizers for ultra-high-purity, low-solvent isolation.
- Inline PAT probes (Inline PAT Probes):
- FBRM (focused-beam reflectance) tracking crystal chord-length distribution in real time;
- PVM (particle video microscopy) imaging crystal shape and habit;
- ReactIR mid-IR tracking solution concentration and supersaturation for feedback cooling.
- Parallel screening & QbD control (Parallel Screening & QbD Control):
- Technobis Crystal16 / Crystalline parallel platforms sweeping solvent and cooling-rate space overnight;
- Quality-by-Design cooling profiles under ICH Q8 that hold the process inside the design space for polymorph control.
Sources 6 · 0 independent · 6 producer sites
Producers' own sites 6
- Technobis producer checked 2026-07-16 · link not kept
- Sulzer producer checked 2026-06-29 · link not kept
- Gea group producer checked 2026-06-22 · link not kept
- Syrris producer checked 2026-05-14 · link not kept
- Alfa laval producer checked 2026-07-17 · link not kept
- Mettler toledo producer checked 2026-03-27 · link not kept